13F

Stock

Tempest Therapeutics, Inc.

TPST · held by 21 managers

Reported value

$2.26M

Holders

21

+0 new · −0 exited

Holders’ est. mark

−$15.5K

Price effect on 2 books still in the name

Largest holder

$774.2K

Versant Venture Management, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Versant Venture Management, LLC269.8K$774.2KHeld
SABBY MANAGEMENT, LLC178.6K$512.6KHeld
Vanguard162.6K$466.5KHeld
GEODE CAPITAL MANAGEMENT, LLC44.1K$126.6KHeld
BlackRock, Inc.39.1K$112.1KHeld
Fidelity33.2K$95.4KHeld
UBS Group AG17.5K$50.3KHeld
NORTHERN TRUST CORP14.1K$40.3KHeld
DIMENSIONAL FUND ADVISORS LP11.4K$32.8KHeld
DRW Securities, LLC10.4K$30KHeld
MORGAN STANLEY2.06K$5.91K−$15.2KCut−$15.8K
OSAIC HOLDINGS, INC.1.61K$4.62KHeld
Tower Research Capital LLC (TRC)1.32K$3.8KHeld
CIBC Private Wealth Group LLC1.08K$3.1KHeld
Federation des caisses Desjardins du Quebec292$838Held
JONES FINANCIAL COMPANIES LLLP239$686Held
SBI Securities Co., Ltd.56$161Held
BANK OF AMERICA CORP /DE/37$107−$274Cut−$274
Parallel Advisors, LLC18$52Held
BNP PARIBAS FINANCIAL MARKETS3$9Held
ROYAL BANK OF CANADA8$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.